- •Apothecary
- •History
- •Other Mentions In Creative Literature
- •Noted Apothecaries
- •See also
- •References
- •Overview
- •Etymology
- •Function
- •Examples
- •See also
- •References
- •Clinical pharmacy
- •[Edit] See also
- •[Edit] References
- •[Edit] External links
- •Compounding
- •History
- •New England Compounding Center incident
- •Roles During research and development
- •Patients with unique or unusual medication needs
- •Personalized medicine and polypharmacy
- •Recent trends
- •Regulation in the United States
- •Analogy to "off-label" use
- •Drug testing and reporting of incidents
- •Criticism
- •Regulation in Australia
- •See also
- •References
- •External links
- •Consultant pharmacist
- •United States
- •United Kingdom
- •See also
- •External links
- •Etymology
- •Medication
- •Spiritual and religious use
- •Self-improvement
- •Recreational drug use
- •Administering drugs
- •See also
- •References
- •Health care
- •Health care delivery
- •Primary care
- •Secondary Care
- •Tertiary care
- •Quaternary care
- •Home and community care
- •Related sectors
- •Health system
- •Health care industry
- •Health care research
- •Health care financing
- •Health care administration and regulation
- •Health information technology
- •See also
- •Herbalism
- •History
- •Ancient times
- •Middle Ages
- •Early modern era
- •Modern herbal medicine
- •Biological background
- •Clinical tests
- •Prevalence of use
- •Herbal preparations
- •Practitioners
- •Government regulations
- •Traditional herbal medicine systems
- •Herbal philosophy and spiritual practices
- •Uses of herbal medicines by animals
- •Extinction of medicinal plant species
- •See also
- •References
- •Further reading
- •History of pharmacy
- •Prehistoric pharmacy
- •Antiquity
- •Middle Ages
- •See also
- •References
- •Hospice
- •History Early development
- •Rise of the modern hospice movement
- •Hospice care
- •North America Canada
- •United States
- •United Kingdom
- •Other nations
- •See also
- •Further reading
- •External links
- •Hospital pharmacy
- •Sterile production
- •See also
- •External links
- •Hospital
- •Etymology
- •General
- •District
- •Specialized
- •Teaching
- •Clinics
- •Departments
- •History Early examples
- •Roman Empire
- •Medieval Islamic world
- •Medieval Europe
- •Colonial America
- •Modern era
- •Criticism
- •Funding
- •Buildings Architecture
- •See also
- •References
- •Bibliography
- •External links
- •Medical education
- •Entry-level education
- •Postgraduate education
- •Continuing medical education
- •Online learning
- •Example of medical education systems
- •Medical Education Journals
- •See also
- •References
- •External links
- •Medical ethics
- •History
- •Values in medical ethics
- •Autonomy
- •Beneficence
- •Non-Maleficence
- •Double effect
- •Conflicts between autonomy and beneficence/non-maleficence
- •Euthanasia
- •Informed consent
- •Confidentiality
- •Criticisms of orthodox medical ethics
- •Importance of communication
- •Control and resolution
- •Guidelines
- •Ethics committees
- •Medical ethics in an online world
- •Cultural concerns
- •Truth-telling
- •Online business practices
- •Conflicts of interest
- •Referral
- •Vendor relationships
- •Treatment of family members
- •Sexual relationships
- •Futility
- •Sources and references
- •External links
- •Medical psychology
- •Behavioral medicine
- •Certifications
- •References
- •See also
- •External links
- •Institutions
- •Branches
- •Basic sciences
- •'Medicine' as a specialty
- •Diagnostic specialties
- •Other major specialties
- •Interdisciplinary fields
- •Education
- •Medical ethics
- •Legal controls
- •Criticism of modern medicine
- •Honors and awards
- •History
- •Ancient world
- •Middle ages
- •Patron saints
- •Nobel Prize in Physiology or Medicine
- •Background
- •Nomination and selection
- •Diplomas
- •Award money
- •Ceremony and banquet
- •Laureates
- •Time factor and death
- •Controversial inclusions and exclusions
- •Limits on number of awardees
- •Years without awards
- •References
- •Bibliography
- •[Edit] External links
- •Online pharmacy
- •Home delivery
- •Risks and concerns
- •Discussion
- •International consumers
- •U.S. Consumers
- •Overseas online pharmacies and u.S. Law
- •Enforcement
- •Mail fraud
- •Uk consumers
- •See also
- •References
- •External links
- •Pharmacist
- •Nature of the work
- •Education and credentialing
- •Practice specialization
- •Training and practice by country
- •Australia
- •Japan History
- •Contemporary
- •Tanzania
- •United Kingdom
- •Education and registration
- •Vietnam
- •United States
- •Pharmacy School Accreditation
- •Education
- •Specialization and credentialing
- •Earnings and wages
- •Noted people who were pharmacists
- •See also
- •References
- •Further reading
- •External links
- •Pharmacognosy
- •Introduction
- •Issues in phytotherapy
- •Constituents and drug synergysm
- •Herb and drug interactions
- •Natural products chemistry
- •Loss of biodiversity
- •Sustainable sources of plant and animal drugs
- •Acceptance in the United States
- •External links
- •References
- •Pharmacology
- •Divisions
- •Environmental pharmacology
- •Scientific background
- •Medicine development and safety testing
- •Drug legislation and safety
- •Education
- •See also
- •Footnotes
- •[Edit] External links
- •Pharmacopoeia
- •Etymology
- •History
- •City pharmacopoeia
- •National pharmacopoeia
- •International pharmacopoeia
- •Medical preparations, uses and dosages
- •See also
- •References
- •External links
- •Pharmacy automation
- •History
- •Chronology
- •Global variations
- •Current state of the industry
- •Technological changes and design improvements
- •Other pharmacy-dispensing concerns besides counting
- •Future development
- •Liquid Oral doses (Childs, aging, oncology...)
- •Repackaging process and stability data
- •See also
- •References
- •External links
- •Videos of robots in action
- •Pharmacy technician
- •See also
- •References
- •External links
- •Pharmacy
- •Disciplines
- •Professionals
- •Pharmacists
- •Pharmacy technicians
- •History
- •Types of pharmacy practice areas
- •Community pharmacy
- •Hospital pharmacy
- •Clinical pharmacy
- •Ambulatory care pharmacy
- •Compounding pharmacy
- •Consultant pharmacy
- •Internet pharmacy
- •Veterinary pharmacy
- •Nuclear pharmacy
- •Military pharmacy
- •Pharmacy informatics
- •Issues in pharmacy Separation of prescribing from dispensing
- •The future of pharmacy
- •Pharmacy journals
- •See also
- •Symbols
- •References
- •External links
- •Philosophy of healthcare
- •Ethics of healthcare
- •Medical ethics
- •Nursing ethics
- •Business ethics
- •Political philosophy of healthcare
- •Patients' Bill of Rights
- •Health insurance
- •Research and scholarship
- •Clinical trials
- •Quality assurance
- •Birth and death Reproductive rights
- •Birth and living
- •Death and dying
- •Role development
- •See also
- •References
- •External links
Beneficence
The term beneficence refers to actions that promote the well being of others. In the medical context, this means taking actions that serve the best interests of patients. However, uncertainty surrounds the precise definition of which practices do in fact help patients.
James Childress and Tom Beauchamp in Principle of Biomedical Ethics (1978) identify beneficence as one of the core values of health care ethics. Some scholars, such as Edmund Pellegrino, argue that beneficence is the only fundamental principle of medical ethics. They argue that healing should be the sole purpose of medicine, and that endeavors like cosmetic surgery, contraception and euthanasia fall beyond its purview.
Non-Maleficence
Main article: Primum non nocere
The concept of non-maleficence is embodied by the phrase, "first, do no harm," or the Latin, primum non nocere. Many consider that should be the main or primary consideration (hence primum): that it is more important not to harm your patient, than to do them good. This is partly because enthusiastic practitioners are prone to using treatments that they believe will do good, without first having evaluated them adequately to ensure they do no (or only acceptable levels of) harm. Much harm has been done to patients as a result, as in the saying, "The treatment was a success, but the patient died." It is not only more important to do no harm than to do good; it is also important to know how likely it is that your treatment will harm a patient. So a physician should go further than not prescribing medications they know to be harmful - he or she should not prescribe medications (or otherwise treat the patient) unless s/he knows that the treatment is unlikely to be harmful; or at the very least, that patient understands the risks and benefits, and that the likely benefits outweigh the likely risks.
In practice, however, many treatments carry some risk of harm. In some circumstances, e.g. in desperate situations where the outcome without treatment will be grave, risky treatments that stand a high chance of harming the patient will be justified, as the risk of not treating is also very likely to do harm. So the principle of non-maleficence is not absolute, and balances against the principle of beneficence (doing good), as the effects of the two principles together often give rise to a double effect (further described in next section).
Depending on the cultural consensus conditioning (expressed by its religious, political and legal social system) the legal definition of non-maleficence differs. Violation of non-maleficence is the subject of medical malpractice litigation. Regulations therefore differ over time, per nation.
Double effect
Main article: Principle of double effect
Double effect refers to two types of consequences which may be produced by a single action,[8] and in medical ethics it is usually regarded as the combined effect of beneficence and non-maleficence.[9]
A commonly cited example of this phenomenon is the use of morphine or other analgesic in the dying patient.[10] Such use of morphine can have the beneficial effect of easing the pain and suffering of the patient, while simultaneously having the maleficent effect of hastening the death of the patient through suppression of the respiratory system.